Strategy reduced nephropathy risky by 21% in patients with type 2 diabetes, study finds. Intensive glucose control with gliclazide (modified release) and other agents reduced the risk of nephropathy ...

We randomly assigned 11,140 patients with type 2 diabetes to undergo either standard glucose control or intensive glucose control, defined as the use of gliclazide (modified release) plus other drugs ...

Please provide your email address to receive an email when new articles are posted on . Using intensive blood pressure control in patients with stages 4 to 5 chronic kidney disease may delay the onset ...

This carefully designed meta-analysis combined results from 5 recent clinical trials to shed further light on the confusing question of whether intensive glycemic control reduces the risk for ...

Two studies provide additional support for lowering systolic blood pressure to an intensive goal of 120 mmHg – far below the standard guidelines of 140 mmHg – to reduce the risk of heart disease in ...

(HealthDay News) — During long-term follow-up, the impact of a 4-year period of intensive glycemic control has a neutral effect on death and nonfatal cardiovascular events, according to a study ...

Researchers have projected that aggressively lowering blood pressure could help prevent more than 100,000 deaths in the U.S. each year. "The public health impact of adopting intensive treatment in the ...

Please provide your email address to receive an email when new articles are posted on . In patients who had endovascular thrombectomy for acute ischemic stroke with large-vessel occlusion, intensive ...

The belief that the lower the glucose level the better in patients with type 2 diabetes who are at a high risk for MI or stroke has been called into question by an ongoing NIH-supported trial.

SAN FRANCISCO, CA—In the SPRINT trial, patients who were treated to an intensive versus standard blood pressure goal had a lower risk of developing LV conduction disease, which hasn’t been considered ...